Immune-related signature identifies IL1R2 as an immunological and prognostic biomarker in pancreatic cancer
{{output}}
Objective: Pancreatic cancer is one of the most aggressive malignancies, a robust prognostic signature and novel biomarkers are urgently needed for accurate stratification of the patients and optimization of clinical decision-mak... ...
